{"disease":{"id":"oral-squamous","name":"oral squamous"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT05049408","title":"Verification of Saliva MMP-1 as a Diagnostic Marker of Oral Cavity Cancer","phase":"","overall_status":"COMPLETED","enrollment_count":1160,"lead_sponsor_name":"S&T Biomed Co., Ltd.","has_results":false},{"nct_id":"NCT02834013","title":"Nivolumab and Ipilimumab in Treating Patients With Rare Tumors","phase":"PHASE2","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":818,"lead_sponsor_name":"National Cancer Institute (NCI)","has_results":false},{"nct_id":"NCT04333537","title":"Comparing Sentinel Lymph Node (SLN) Biopsy With Standard Neck Dissection for Patients With Early-Stage Oral Cavity Cancer","phase":"PHASE2, PHASE3","overall_status":"RECRUITING","enrollment_count":686,"lead_sponsor_name":"NRG Oncology","has_results":false},{"nct_id":"NCT01810913","title":"Testing Docetaxel-Cetuximab or the Addition of an Immunotherapy Drug, Atezolizumab, to the Usual Chemotherapy and Radiation Therapy in High-Risk Head and Neck Cancer","phase":"PHASE2, PHASE3","overall_status":"RECRUITING","enrollment_count":613,"lead_sponsor_name":"National Cancer Institute (NCI)","has_results":false},{"nct_id":"NCT01473784","title":"Transoral Robotic Surgery in Treating Patients With Benign or Malignant Tumors of the Head and Neck","phase":"NA","overall_status":"RECRUITING","enrollment_count":600,"lead_sponsor_name":"Ohio State University Comprehensive Cancer Center","has_results":false},{"nct_id":"NCT04543266","title":"Predicting Metastatic Oral Squamous Cell Carcinomas With Molecular Biomarkers Using Machine Learning","phase":"","overall_status":"UNKNOWN","enrollment_count":500,"lead_sponsor_name":"The University of Hong Kong","has_results":false},{"nct_id":"NCT06438939","title":"NBI for Early Diagnosis of OPMD/OSCC","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":480,"lead_sponsor_name":"Cardarelli Hospital","has_results":false},{"nct_id":"NCT05063552","title":"Testing the Use of Investigational Drugs Atezolizumab and/or Bevacizumab With or Without Standard Chemotherapy in the Second-Line Treatment of Advanced-Stage Head and Neck Cancers","phase":"PHASE2, PHASE3","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":430,"lead_sponsor_name":"National Cancer Institute (NCI)","has_results":false},{"nct_id":"NCT06016400","title":"Using Vitamin D to Reduce Oral Mucosal Inflammation in Chemotherapy Patients With Oral Squamous Cell Carcinoma","phase":"PHASE2, PHASE3","overall_status":"UNKNOWN","enrollment_count":412,"lead_sponsor_name":"Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University","has_results":false},{"nct_id":"NCT00588770","title":"Chemotherapy With or Without Bevacizumab in Treating Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma","phase":"PHASE3","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":403,"lead_sponsor_name":"National Cancer Institute (NCI)","has_results":true},{"nct_id":"NCT06336941","title":"\"Ultra-High Frequency intraOral UltraSonography of the TONgue\" (HOUSTON)","phase":"NA","overall_status":"RECRUITING","enrollment_count":400,"lead_sponsor_name":"University of Pisa","has_results":false},{"nct_id":"NCT05798793","title":"Neoadjuvant Anti-PD-1 Immunotherapy With Chemotherapy in Resectable Locally Advanced Oral Squamous Cell Carcinoma","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":309,"lead_sponsor_name":"Hospital of Stomatology, Wuhan University","has_results":false},{"nct_id":"NCT04270201","title":"Determination of ALDH1b1 and ALDH2 Polymorphisms Frequency in the Brazilian Population","phase":"","overall_status":"UNKNOWN","enrollment_count":300,"lead_sponsor_name":"Instituto do Cancer do Estado de São Paulo","has_results":false},{"nct_id":"NCT05721755","title":"Combining Radiation Therapy With Immunotherapy for the Treatment of Metastatic Squamous Cell Carcinoma of the Head and Neck","phase":"PHASE3","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":290,"lead_sponsor_name":"ECOG-ACRIN Cancer Research Group","has_results":false},{"nct_id":"NCT06947668","title":"Immune Biomarker Study for Cisplatin-ineligible Patients Receiving Chemoradiotherapy With Docetaxel","phase":"","overall_status":"RECRUITING","enrollment_count":250,"lead_sponsor_name":"University of Erlangen-Nürnberg Medical School","has_results":false},{"nct_id":"NCT02923258","title":"Postoperative CCRT With Docetaxel vs Cisplatin in High Risk Oral Cavity Cancer","phase":"PHASE2, PHASE3","overall_status":"COMPLETED","enrollment_count":224,"lead_sponsor_name":"Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University","has_results":false},{"nct_id":"NCT06599801","title":"Clinical Outcomes of Thoracodorsal Artery Flap in Oral and Maxillofacial Reconstruction","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":217,"lead_sponsor_name":"Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University","has_results":false},{"nct_id":"NCT06321003","title":"SYsteMatical Trained learnIng aLgorithms for Oral carcInogenesiS Interpretation by Optical Coherence Tomography","phase":"","overall_status":"RECRUITING","enrollment_count":200,"lead_sponsor_name":"University of Palermo","has_results":false},{"nct_id":"NCT04821128","title":"Radio/Pathological Evaluation of Tongue Cancer Infiltration","phase":"","overall_status":"UNKNOWN","enrollment_count":200,"lead_sponsor_name":"Hospices Civils de Lyon","has_results":false},{"nct_id":"NCT03258554","title":"Radiation Therapy With Durvalumab or Cetuximab in Treating Patients With Locoregionally Advanced Head and Neck Cancer Who Cannot Take Cisplatin","phase":"PHASE2, PHASE3","overall_status":"COMPLETED","enrollment_count":196,"lead_sponsor_name":"National Cancer Institute (NCI)","has_results":true},{"nct_id":"NCT05455632","title":"Postoperative Radiotherapy for Oral Squamous Cell Carcinoma After Neoadjuvant Therapy and Surgery","phase":"","overall_status":"COMPLETED","enrollment_count":192,"lead_sponsor_name":"Shanghai Jiao Tong University School of Medicine","has_results":false},{"nct_id":"NCT05551117","title":"A Study of Vobramitamab Duocarmazine in Participants With Metastatic Castration Resistant Prostate Cancer and Other Solid Tumors","phase":"PHASE2","overall_status":"TERMINATED","enrollment_count":192,"lead_sponsor_name":"MacroGenics","has_results":true},{"nct_id":"NCT07402525","title":"Postoperative Radiotherapy for Early-stage Oral Tongue Squamous Cell Carcinoma Patients With Risk Factors: a Prospective, Multicenter, Randomized Controlled, Open-labelled Trial","phase":"NA","overall_status":"RECRUITING","enrollment_count":190,"lead_sponsor_name":"Second Affiliated Hospital, School of Medicine, Zhejiang University","has_results":false},{"nct_id":"NCT02734537","title":"Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III-IVA Squamous Cell Carcinoma of the Head and Neck Who Have Undergone Surgery","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":189,"lead_sponsor_name":"ECOG-ACRIN Cancer Research Group","has_results":false},{"nct_id":"NCT04671667","title":"Testing What Happens When an Immunotherapy Drug (Pembrolizumab) is Given by Itself Compared to the Usual Treatment of Chemotherapy With Radiation After Surgery for Recurrent Head and Neck Squamous Cell Carcinoma","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":188,"lead_sponsor_name":"National Cancer Institute (NCI)","has_results":false},{"nct_id":"NCT07195734","title":"Testing the Addition of Chemotherapy or Chemo-Immunotherapy to the Usual Surgery for Advanced Head and Neck Cancer","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":180,"lead_sponsor_name":"National Cancer Institute (NCI)","has_results":false},{"nct_id":"NCT03917524","title":"Feasibility of CTCs Isolation for Transcriptomes and Genome Wide Associated Analysis in Post-OP High Risk OSCC Patients.","phase":"","overall_status":"UNKNOWN","enrollment_count":180,"lead_sponsor_name":"Chang Gung Memorial Hospital","has_results":false},{"nct_id":"NCT05075980","title":"Intensity Modulated Proton or X-Ray Therapy After Surgery for Treatment of Head and Neck Cancer, the HEADLIGHT Study","phase":"PHASE2","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":174,"lead_sponsor_name":"Mayo Clinic","has_results":false},{"nct_id":"NCT06589804","title":"Testing the Addition of Anti-Cancer Drug, Cetuximab, to Standard of Care Treatment (Pembrolizumab) for Returning or Spreading Head and Neck Cancer After Previous Treatment","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":158,"lead_sponsor_name":"National Cancer Institute (NCI)","has_results":false},{"nct_id":"NCT05136196","title":"BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":150,"lead_sponsor_name":"National Cancer Institute (NCI)","has_results":false},{"nct_id":"NCT03418454","title":"The Oral Microbiome as a Prognostic Tool in Oral Malignant and Premalignant Lesions and in Medication Related Osteonecrosis of the Jaw","phase":"","overall_status":"UNKNOWN","enrollment_count":150,"lead_sponsor_name":"Barzilai Medical Center","has_results":false},{"nct_id":"NCT06055868","title":"People Living With HIV, Oral and Oropharyngeal Cancer, and Health Equity","phase":"","overall_status":"RECRUITING","enrollment_count":144,"lead_sponsor_name":"University of California, San Francisco","has_results":false},{"nct_id":"NCT06258811","title":"Neoadjuvant Immunochemotherapy for LAOSCC","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":134,"lead_sponsor_name":"Lai-ping Zhong","has_results":false},{"nct_id":"NCT04725396","title":"Study Comparing Fibula Free-flap MR With or Without PVP in Patients With OOPC","phase":"NA","overall_status":"COMPLETED","enrollment_count":132,"lead_sponsor_name":"UNICANCER","has_results":false},{"nct_id":"NCT02245100","title":"Circulating Tumor DNA in Predicting Outcomes in Patients With Stage IV Head and Neck Cancer or Stage III-IV Non-small Cell Lung Cancer","phase":"","overall_status":"COMPLETED","enrollment_count":130,"lead_sponsor_name":"Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University","has_results":false},{"nct_id":"NCT01064479","title":"Combination Chemotherapy With or Without Erlotinib Hydrochloride in Treating Patients With Metastatic or Recurrent Squamous Cell Carcinoma of the Head and Neck","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":123,"lead_sponsor_name":"M.D. Anderson Cancer Center","has_results":true},{"nct_id":"NCT06662058","title":"Remote Audiometry to Monitor for Treatment-Related Hearing Loss in Patients With H&N SCC Receiving Cisplatin and/or Radiation","phase":"NA","overall_status":"RECRUITING","enrollment_count":118,"lead_sponsor_name":"Emory University","has_results":false},{"nct_id":"NCT05950737","title":"Sentinel Node Biopsy in Early Oral Cancers a Tertiary Cancer Centre Experience","phase":"NA","overall_status":"COMPLETED","enrollment_count":115,"lead_sponsor_name":"Tata Memorial Hospital","has_results":false},{"nct_id":"NCT05150509","title":"Association of Salivary Amino Acid Level With OSCC Identified By Liquid Chromatography Mass Spectroscopy","phase":"","overall_status":"UNKNOWN","enrollment_count":110,"lead_sponsor_name":"DR. MALA KHAN","has_results":false},{"nct_id":"NCT06009861","title":"Neoadjuvant Tislelizumab Plus Chemotherapy for Locally Advanced Oral/Oropharyngeal Cancer (NeoSPOT)","phase":"PHASE2","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":110,"lead_sponsor_name":"Peking University Hospital of Stomatology","has_results":false},{"nct_id":"NCT06701058","title":"Active MMP-8 in Oral Fluid for the Detection of Oral and Oropharyngeal Cancer","phase":"","overall_status":"COMPLETED","enrollment_count":107,"lead_sponsor_name":"Helsinki University Central Hospital","has_results":false},{"nct_id":"NCT07371611","title":"Sintilimab Plus Chemotherapy as Neoadjuvant and Adjuvant Treatment for Locally Advanced Oral Squamous Cell Carcinoma","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":104,"lead_sponsor_name":"Qunxing Li,MD","has_results":false},{"nct_id":"NCT03529604","title":"Salivary Ap4A, SCCA, TROP2 in Oral Cancer Patients","phase":"","overall_status":"UNKNOWN","enrollment_count":100,"lead_sponsor_name":"University of Zagreb","has_results":false},{"nct_id":"NCT06532279","title":"Testing the Addition of the Drug BMX-001, a Radioprotector, or a Placebo to the Usual Chemoradiation Therapy for Patients With Head and Neck Cancer","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":98,"lead_sponsor_name":"NRG Oncology","has_results":false},{"nct_id":"NCT03370276","title":"Cetuximab & Nivolumab in Patients With Recurrent/Metastatic Head & Neck Squamous Cell Carcinoma","phase":"PHASE1, PHASE2","overall_status":"COMPLETED","enrollment_count":95,"lead_sponsor_name":"H. Lee Moffitt Cancer Center and Research Institute","has_results":true},{"nct_id":"NCT06259838","title":"Oral Cavity Squamous Cell Carcinoma and Readmission: Rates, Causes, and Risk Factors.","phase":"","overall_status":"COMPLETED","enrollment_count":93,"lead_sponsor_name":"Abdulsalam Alqutub","has_results":false},{"nct_id":"NCT07457099","title":"Impact of Postoperative Radiotherapy Versus PD-1 Inhibitor Maintenance on Survival in Resectable Locally Advanced Oral and Oropharyngeal Squamous Cell Carcinoma","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":85,"lead_sponsor_name":"Zhujiang Hospital","has_results":false},{"nct_id":"NCT07180901","title":"Proactive Risk-based Optimization & Notifications for Treatment & Outcomes in Head & Neck Cancer","phase":"NA","overall_status":"RECRUITING","enrollment_count":85,"lead_sponsor_name":"Centre hospitalier de l'Université de Montréal (CHUM)","has_results":false},{"nct_id":"NCT03148665","title":"Saliva-based Detection of CD44","phase":"","overall_status":"COMPLETED","enrollment_count":85,"lead_sponsor_name":"Joseph Califano","has_results":false},{"nct_id":"NCT05927220","title":"WORST PATTERN OF INVASION IN ORAL SQUAMOUS CELL CARCINOMA","phase":"","overall_status":"UNKNOWN","enrollment_count":81,"lead_sponsor_name":"Armed Forces Institute of Pathology Rawalpindi","has_results":false}],"total":50},"guidelines":[],"source":"Drug Landscape verified database"}